Cytokinetics CYTK Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $129.84M+76.2% | $122.52M+29.2% | $225.47M+381% | $74.94M-60.6% | $73.68M-38.6% | ||
| $688.71M-20.3% | $759.7M-22.6% | $737.07M-23.6% | $783.2M-9.6% | $864.54M+73.3% | ||
| $6.83M+239% | $17.76M+6.7% | $1.81M+641% | $8.41M— | $2.01M+141% | ||
| $3.84M— | $0— | —— | —— | $0— | ||
| $13.93M-11.9% | $16.99M+11.2% | $13.01M+95.1% | $20M+81.2% | $15.82M-16.3% | ||
| $839.47M-12.2% | $916.98M-17.2% | $977.35M-4.0% | $886.54M-17.0% | $956.05M+49.7% | ||
| $82.44M+22.7% | $79.19M+20.3% | $76M+18.3% | $70.22M+6.9% | $67.18M-1.2% | ||
| $74.55M-3.7% | $75.98M+1.1% | $77.58M+1.6% | $76.12M-1.5% | $77.44M-0.9% | ||
| $18.47M+45.5% | $17.34M+125% | $16.81M+118% | $14.55M+89.5% | $12.7M+62.5% | ||
| $254.72M+69.0% | $335.05M+131% | $288.82M+7.3% | $178.2M-41.6% | $150.69M+880% | ||
| $1.27B+0.7% | $1.42B+1.6% | $1.44B0.0% | $1.23B-19.6% | $1.26B+56.4% | ||
| $24.71M+77.2% | $22.34M+9.7% | $22.08M+90.7% | $16.23M+71.4% | $13.94M+7.5% | ||
| $8.59M+47.6% | $3.83M-60.9% | $1.99M-64.0% | $9.59M-6.6% | $5.82M-3.2% | ||
| $1.65M-96.8% | $1.61M-96.9% | $1.61M— | $1.34M— | $52.37M— | ||
| $44.81M+246% | $41.18M+257% | $17.28M+50.0% | $14.4M+25.0% | $12.96M+12.5% | ||
| $20.96M+7.1% | $19.11M+0.7% | $20.65M+9.5% | $19.59M+5.8% | $19.57M+7.4% | ||
| $199.19M+24.7% | $202.45M+12.7% | $142.14M+29.4% | $131.06M+27.5% | $159.73M+79.8% | ||
| $247.21M+169% | $246.38M+164% | $158.75M+70.7% | $159.06M+71.3% | $92.03M+62.0% | ||
| $105.24M-7.2% | $107.97M-4.1% | $110.66M-3.6% | $111.03M-4.9% | $113.35M-4.4% | ||
| —— | —— | $1.61M— | $2.02M— | $2.82M+140,950% | ||
| $2.1B+37.2% | $2.08B+35.6% | $1.96B+35.0% | $1.59B+12.7% | $1.53B+27.1% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $124K+4.2% | $123K+4.2% | $122K+3.4% | $119K+1.7% | $119K+13.3% | ||
| $2.87B+10.5% | $2.83B+10.2% | $2.78B+9.9% | $2.63B+5.1% | $2.6B+40.1% | ||
| -$3.69B-29.0% | -$3.49B-29.1% | -$3.3B-29.5% | -$3B-25.4% | -$2.86B-27.4% | ||
| -$1.61M-204% | $630K-73.7% | $34K-99.4% | -$158K+84.5% | $1.55M+387% | ||
| -$826.57M-210% | -$659.63M-387% | -$521.12M-3,646% | -$368.72M-440% | -$266.41M+32.8% | ||
| $1.27B+0.7% | $1.42B+1.6% | $1.44B0.0% | $1.23B-19.6% | $1.26B+56.4% | ||
| —— | —— | —— | —— | —— | ||
| $688.71M-20.3% | $759.7M-22.6% | $737.07M-23.6% | $783.2M-9.6% | $864.54M+73.3% | ||
| $18.47M+45.5% | $17.34M+125% | $16.81M+118% | $14.55M+89.5% | $12.7M+62.5% | ||
| $74.55M-3.7% | $75.98M+1.1% | $77.58M+1.6% | $76.12M-1.5% | $77.44M-0.9% | ||
| $254.72M+69.0% | $335.05M+131% | $288.82M+7.3% | $178.2M-41.6% | $150.69M+880% | ||
| $74.55M-3.7% | $75.98M+1.1% | $77.58M+1.6% | $76.12M-1.5% | $77.44M-0.9% | ||
| $18.47M+45.5% | $17.34M+125% | $16.81M+118% | $14.55M+89.5% | $12.7M+62.5% | ||
| $74.55M-3.7% | $75.98M+1.1% | $77.58M+1.6% | $76.12M-1.5% | $77.44M-0.9% | ||
| $18.47M+45.5% | $17.34M+125% | $16.81M+118% | $14.55M+89.5% | $12.7M+62.5% | ||
| $68.86M+58.8% | $83.28M+50.5% | $61.63M+23.7% | $52.32M+31.4% | $43.36M+8.1% | ||
| $68.86M+58.8% | $83.28M+50.5% | $61.63M+23.7% | $52.32M+31.4% | $43.36M+8.1% | ||
| $1.65M-96.8% | $1.61M-96.9% | $1.61M— | $1.34M— | $52.37M— | ||
| $29.6M+153% | $31.1M+175% | $16.9M+35.2% | $17.6M+33.3% | $11.7M— | ||
| $8.59M+47.6% | $3.83M-60.9% | $1.99M-64.0% | $9.59M-6.6% | $5.82M-3.2% | ||
| $29.6M+153% | $31.1M+175% | $16.9M+35.2% | $17.6M+33.3% | $11.7M— | ||
| $418.21M+75.8% | $414.65M+75.3% | $307.33M+29.1% | $304.07M+26.9% | $237.91M+16.0% | ||
| $2.87B+10.5% | $2.83B+10.2% | $2.78B+9.9% | $2.63B+5.1% | $2.6B+40.1% | ||
| $124K+4.2% | $123K+4.2% | $122K+3.4% | $119K+1.7% | $119K+13.3% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $870.51M— | $869.6M+57.4% | —— | —— | —— | ||
| $539.11M+13.2% | $520.56M+12.6% | $504.5M+12.5% | $489.5M+12.5% | $476.3M+22.1% | ||
| $138.8M+4.3% | $137.2M+0.1% | $150.5M+13.7% | $147.7M+26.0% | $133.1M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cytokinetics's total assets?
- Cytokinetics (CYTK) holds $1.3B in total assets, up 0.8% year over year.
- How much debt does Cytokinetics have?
- Cytokinetics carries $418.2M in total debt against -$826.6M of shareholders' equity, a debt-to-equity ratio of 2.21.
- How much cash does Cytokinetics have?
- Cytokinetics holds $129.8M in cash and equivalents.
- Can Cytokinetics cover its short-term obligations?
- Its current ratio is 4.21 — current assets exceed current liabilities.
- Where does Cytokinetics's balance sheet data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
